1. Home
  2. BDSX vs QBTS Comparison

BDSX vs QBTS Comparison

Compare BDSX & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • QBTS
  • Stock Information
  • Founded
  • BDSX 2005
  • QBTS 1999
  • Country
  • BDSX United States
  • QBTS Canada
  • Employees
  • BDSX N/A
  • QBTS N/A
  • Industry
  • BDSX Precision Instruments
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • BDSX Health Care
  • QBTS Technology
  • Exchange
  • BDSX Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • BDSX 194.9M
  • QBTS 194.5M
  • IPO Year
  • BDSX 2020
  • QBTS N/A
  • Fundamental
  • Price
  • BDSX $1.51
  • QBTS $7.42
  • Analyst Decision
  • BDSX Strong Buy
  • QBTS Strong Buy
  • Analyst Count
  • BDSX 4
  • QBTS 6
  • Target Price
  • BDSX $3.08
  • QBTS $5.63
  • AVG Volume (30 Days)
  • BDSX 332.5K
  • QBTS 84.7M
  • Earning Date
  • BDSX 11-01-2024
  • QBTS 11-14-2024
  • Dividend Yield
  • BDSX N/A
  • QBTS N/A
  • EPS Growth
  • BDSX N/A
  • QBTS N/A
  • EPS
  • BDSX N/A
  • QBTS N/A
  • Revenue
  • BDSX $65,562,000.00
  • QBTS $9,424,000.00
  • Revenue This Year
  • BDSX $46.97
  • QBTS $4.82
  • Revenue Next Year
  • BDSX $30.43
  • QBTS $64.23
  • P/E Ratio
  • BDSX N/A
  • QBTS N/A
  • Revenue Growth
  • BDSX 48.92
  • QBTS 14.27
  • 52 Week Low
  • BDSX $1.11
  • QBTS $0.68
  • 52 Week High
  • BDSX $2.21
  • QBTS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 48.94
  • QBTS 62.66
  • Support Level
  • BDSX $1.24
  • QBTS $3.71
  • Resistance Level
  • BDSX $1.43
  • QBTS $10.50
  • Average True Range (ATR)
  • BDSX 0.10
  • QBTS 1.48
  • MACD
  • BDSX 0.01
  • QBTS 0.26
  • Stochastic Oscillator
  • BDSX 64.44
  • QBTS 50.23

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is engaged in the development and delivery of quantum computing systems, software, and services, and is the commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modelling. D-Wave's annealing quantum computers are accessible through the Company's LeapTM cloud service.

Share on Social Networks: